An Overview of Pharmacological Profile of Flavonoids as Potential Molecules of Therapeutic Importance

Abstract: A growing number of research investigations have shown the multiple health benefits of flavonoids derived from plants, leading to interest in the field. Many recent studies have concentrated on flavonoids effects on human health. Flavonoids are effective against a wide spectrum of bacteria, viruses, and other pathogens. Numerous flavonoids have been demonstrated to possess antioxidative, free radical scavenging, hepatoprotective, antiinflammatory, anticancer, and coronary heart disease preventive properties. Some of novel flavonoids having therapeutic potential as new medication have been identified which include hesperetin-5′-O-β-rhamnoglucoside, Resveratrol, Astragalin (AST) Desmodinosides A-E: New Flavonoid C-glycosides, Apigenin, Luteolin, and Baicalein, rutin, hyperoside etc. Some recent developments including clinical trials of a few of the flavonoids discussed in the review provide a novel library of pharmacologically potential molecules which provides a paradigm for the treatment of several ailments such as SARS-CoV-2, Alzheimer's disease, diabetes, angina pectoris, Hepatitis C virus and Sickle cell disease (SCD) etc. The present review aims at updating recent flavonoid advancements for various pharmacological actions, from conventional therapeutic implications to upcoming clinical trials. We encourage researchers to focus on flavonoids for a variety of medicinal applications since the industrial acceptance of these compounds will determine the future growth of this field.